Cargando…
Randomized double blind placebo-controlled trial of Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: improvement in abdominal pain and bloating in those with predominant constipation
BACKGROUND: Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder characterized by recurrent abdominal pain and/or discomfort. Probiotics have been reported to benefit IBS symptoms but the level of benefit remains quite unclear. OBJECTIVE: This study was designed to assess...
Autores principales: | Spiller, Robin, Pélerin, Fanny, Cayzeele Decherf, Amélie, Maudet, Corinne, Housez, Béatrice, Cazaubiel, Murielle, Jüsten, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924426/ https://www.ncbi.nlm.nih.gov/pubmed/27403301 http://dx.doi.org/10.1177/2050640615602571 |
Ejemplares similares
-
Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis
por: Cayzeele-Decherf, Amélie, et al.
Publicado: (2017) -
Saccharomyces cerevisiae I-3856 in irritable bowel syndrome with predominant constipation
por: Mourey, Florian, et al.
Publicado: (2022) -
Saccharomyces cerevisiae CNCM I-3856 as a New Therapeutic Agent Against Oropharyngeal Candidiasis
por: Roselletti, Elena, et al.
Publicado: (2019) -
Anti-Biofilm Properties of Saccharomyces cerevisiae CNCM I-3856 and Lacticaseibacillus rhamnosus ATCC 53103 Probiotics against G. vaginalis
por: Sabbatini, Samuele, et al.
Publicado: (2020) -
Recovery of Saccharomyces cerevisiae CNCM I-3856 in Vaginal Samples of Healthy Women after Oral Administration
por: Decherf, Amelie, et al.
Publicado: (2020)